Bimatoprost ophthalmic solution 0.01% YSBP
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Bimatoprost ophthalmic solution 0.01% YSBP for glaucoma, open-angle | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |